Unirisco helps reduce the risk when starting up a business, right from the university.

Mabel Loza – Oncostellae

Oncostellae

Oncostellae is a biotech company specializing in the development of new drugs for the treatment of certain diseases in oncology and autoimmune diseases, such as prostate cancer, Inflammatory Bowel Disease (IBM), psoriasis and severe asthma.

The company’s business model focuses on the discovery of new drugs and on their development from the initial stages to the proof of concept in patients (clinical Phase Ib/IIa) in order to subsequently license the results and patents to pharmaceutical companies.